Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT von Edan, G, Kappos, L, Montalbán, X, Polman, C H, Freedman, M S, Hartung, H-P, Miller, D, Barkhof, F, Herrmann, J, Lanius, V, Stemper, B, Pohl, C, Sandbrink, R, Pleimes, D

Volltext

Evaluation of mutagenicity, genotoxicity and chronic toxicity of antiviral drug imidazolyl ethanamide pentandioic acid in in vitro and in vivo test systems von Jain, E. A., Pleimes, D., Globenko, A. A.

Volltext

Survival in commercially insured multiple sclerosis patients and comparator subjects in the U.S von Kaufman, D.W, Reshef, S, Golub, H.L, Peucker, M, Corwin, M.J, Goodin, D.S, Knappertz, V, Pleimes, D, Cutter, G

Volltext

Benefit 11: Long-term follow-up study of patients with clinically isolated syndrome treated with interferon beta-1b von Kappos, L, Edan, G, Freedman, M, Montalbán, X, Miller, D, Polman, C, Hartung, H.-P, Hemmer, B, Fox, E, Barkhof, F, Schippling, S, Lanius, V, Hermann, J, Pohl, C, Sandbrink, R, Wicklein, E.-M, Pleimes, D

Volltext

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial von Kappos, L, Edan, G, Freedman, M S, Montalbán, X, Hartung, H P, Hemmer, B, Fox, E J, Barkhof, F, Schippling, S, Schulze, A, Pleimes, D, Pohl, C, Sandbrink, R, Suarez, G, Wicklein, E M

Volltext

Optical coherence tomography and ophthalmological findings in patients with CIS treated with interferon beta-1b: 11-year follow-up in BENEFIT (BENEFIT 11) von Lukas, S., Hanson, J. V. M., Edan, Gilles, Freedman, M. S., Montalban, X., Hartung, H. -P., Hemmer, B., Fox, E. J., Barkhof, F., Koelbach, R., Pleimes, D., Pohl, C., Sandbrink, R., Suarez, G., Wicklein, E. -M., Kappos, Ludwig, Schippling, S.

Volltext

MRI results in patients with CIS treated with interferon beta-1b: 11-year follow up in BENEFIT (BENEFIT 11) von Barkhof, F., Wattjes, M. P., Edan, Gilles, Freedman, M. S., Montalban, X., Hartung, H. -P., Hemmer, B., Fox, E. J., Schippling, S., Koelbach, R., Pleimes, D., Pohl, C., Sandbrink, R., Suarez, G., Wicklein, E. -M., Kappos, Ludwig

Volltext

Impact of early treatment of MS with interferon beta-1b: cognitive outcomes at the 11-year follow-up of BENEFIT (BENEFIT 11) von Foley, F., Penner, I. -K., Edan, Gilles, Freedman, M. S., Montalban, X., Hartung, H. -P., Hemmer, B., Fox, E. J., Barkhof, F., Schippling, S., Koelbach, R., Pleimes, D., Pohl, C., Sandbrink, R., Suarez, G., Wicklein, E. -M., Kappos, Ludwig

Volltext

Early Initiation of Interferon Beta-1b after a First Clinical Event Suggestive of Multiple Sclerosis: Clinical Outcomes and Use of Disease-Modifying Therapy from the BENEFIT Extens... von Edan, G., Kappos, L., Montalban, X., Polman, C., Freedman, M., Hartung, H., Miller, D., Barkhof, F., Lanius, V., Stemper, B., Pohl, C., Sandbrink, R., Pleimes, D.

Volltext

Substance P mediates AP-1 induction in A549 cells via reactive oxygen species von Springer, Jochen, Pleimes, Dirk, Scholz, Frank R., Fischer, Axel

Volltext

Characteristic Congenital Reticular Erythema: Cutis Marmorata Telangiectatica Congenita von Pleimes, Marc, MD, Göttler, Susanne, MD, Weibel, Lisa, MD

Volltext

Long-Term Cost-Effectiveness Model of Interferon Beta-1b in the Early Treatment of Multiple Sclerosis in the United States von Pan, Feng, PhD, Goh, Jo Wern, MS, MPhil, Cutter, Gary, PhD, Su, Wayne, MS, Pleimes, Dirk, MD, Wang, Cheng, PhD

Volltext

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial von Kappos, L, Edan, G, Freedman, MS, Montalbán, X, Hartung, H-P, Hemmer, B, Fox, EJ, Barkhof, F, Schippling, S, Schulze, A, Pleimes, D, Pohl, C, Sandbrink, R, Suarez, G, Wicklein, E-M, BENEFIT Study Group

Volltext bestellen

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial von Kappos, Ludwig, Edan, Gilles, Freedman, Mark S, Montalbán, Xavier, Hartung, Hans-Peter, Hemmer, Bernhard, Fox, Edward J, Barkhof, Frederik, Schippling, Sven, Schulze, Andrea, Pleimes, Dirk, Pohl, Christoph, Sandbrink, Rupert, Suarez, Gustavo, Wicklein, Eva-Maria

Volltext

Novel hemophilia B mouse models exhibiting a range of mutations in the Factor IX gene von Sabatino, Denise E., Armstrong, Elina, Edmonson, Shyrie, Liu, Yi-Lin, Pleimes, Marc, Schuettrumpf, Joerg, Fitzgerald, Julie, Herzog, Roland W., Arruda, Valder R., High, Katherine A.

Volltext